Baker Brothers Advisors - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 103 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$153,651,351
+43.4%
6,702,349
+3.1%
0.89%
+42.9%
Q2 2023$107,156,423
-7.6%
6,498,2670.0%0.62%
-1.7%
Q1 2023$115,929,083
-37.4%
6,498,267
+2.3%
0.63%
-43.2%
Q4 2022$185,046,185
+24.6%
6,354,608
+4.8%
1.11%
+14.2%
Q3 2022$148,536,000
+767.7%
6,062,702
+47.0%
0.97%
+903.1%
Q2 2022$17,119,000
-64.0%
4,125,0620.0%0.10%
-64.5%
Q1 2022$47,521,000
+23.3%
4,125,062
+6.8%
0.27%
+45.2%
Q4 2021$38,555,000
-23.6%
3,863,2390.0%0.19%
-15.3%
Q3 2021$50,454,000
-33.3%
3,863,2390.0%0.22%
-33.1%
Q2 2021$75,642,000
+2.2%
3,863,239
+11.0%
0.33%
+3.4%
Q1 2021$74,017,000
+7.6%
3,479,873
+50.3%
0.32%
+23.9%
Q4 2020$68,821,000
+28.5%
2,314,873
-6.3%
0.26%
+21.0%
Q3 2020$53,550,000
-11.1%
2,471,155
-8.5%
0.21%
-19.5%
Q2 2020$60,211,000
+46.1%
2,700,055
-0.3%
0.27%
+4.7%
Q1 2020$41,219,000
-33.7%
2,708,2000.0%0.25%
-23.3%
Q4 2019$62,180,000
+6.3%
2,708,2000.0%0.33%
-16.8%
Q3 2019$58,470,000
-1.9%
2,708,2000.0%0.40%
-1.7%
Q2 2019$59,580,000
-19.7%
2,708,2000.0%0.40%
-14.7%
Q1 2019$74,232,000
+2.0%
2,708,2000.0%0.48%
-20.3%
Q4 2018$72,796,000
-7.9%
2,708,2000.0%0.60%
+14.6%
Q3 2018$78,998,000
-6.7%
2,708,2000.0%0.52%
-18.2%
Q2 2018$84,658,000
+107.6%
2,708,200
+32.2%
0.64%
+83.8%
Q1 2018$40,775,000
-31.5%
2,049,0200.0%0.35%
-32.9%
Q4 2017$59,545,0002,049,0200.52%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 2,075,000$47,569,3755.56%
NEA Management Company, LLC 2,909,956$66,710,7415.15%
Opaleye Management Inc. 653,000$14,970,0254.87%
Frazier Life Sciences Management, L.P. 2,371,304$54,362,1443.61%
VR Adviser, LLC 1,090,000$24,988,2502.63%
RA Capital Management 5,676,067$130,123,8362.56%
Samsara BioCapital, LLC 345,293$7,915,8422.42%
SILVERARC CAPITAL MANAGEMENT, LLC 260,537$5,972,8111.81%
Logos Global Management LP 400,000$9,170,0001.22%
Cormorant Asset Management, LP 850,000$19,486,2501.14%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders